Pathway analysis showed that the TGFβ pathway, RAF pathway, EMT pathway and so on were significantly enriched (P < 0.05) (Fig. 5C), which suggests that these pathways may be involved in ALDH2-mediated PTX resistance in lung cancer. Here, RAF1 is linked to lung carcinoma.